Titlebook: Chronic Kidney Disease and Hypertension; Matthew R. Weir,Edgar V. Lerma Book 2015 Springer Science+Business Media New York 2015 BP Monitor

鎮(zhèn)痛劑

Hypertension in Children with Chronic Kidney Disease,on should be aggressively treated, the optimal target for blood pressure control in children with CKD has not been clearly defined. In most cases, pharmacologic treatment should be initiated with a drug that inhibits the renin–angiotensin–aldosterone system and individualized to the patient.

挑剔為人

POINT

Changes in Guideline Trends and Applications in Practice: JNC 2013 and the Future,e than three decades with the first report published in 1977. The purpose of this report is to provide an authoritative review and summary of available data from clinical trials that will educate and update healthcare providers on approaches to treatment and cardiovascular risk reduction of appropri

拾落穗

動脈

Resistant Hypertension in Patients with Chronic Kidney Disease,e is steadily escalating to hazardous proportions due to the increasing incidence of hypertension, diabetes, metabolic syndrome, and other risk factors. Hypertension can be a cause or consequence of CKD. Nevertheless, the coexistence of hypertension and CKD portends poor prognosis due to the occurre

Carcinogenesis

Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease,ute to hypertension in these patients, including volume expansion and activation of the renin–angiotensin–aldosterone system. This chapter deals with the role of the sympathetic nervous system in hypertension and CKD progression in these patients and with the mechanisms that can contribute to the ac

capillaries

FOIL

大包裹

Renal Sympathetic Denervation,he availability of proven therapeutic approaches including lifestyle modification and the use of antihypertensive drugs, control rates for hypertension remain unsatisfactory across the globe. While the majority of patients can be controlled with adequate combination therapy of drugs with different m

LUMEN

Novel Baroreceptor Activation Therapy,ll or is reduced insufficiently during treatment. Treatment resistance, therefore, is one of the challenges of contemporary hypertension research. Since the autonomic system plays a major role in the pathogenesis of hypertension, in particular when this is resistant to drug treatment, investigators